Parikh

RAAPID Showcases Neuro-Symbolic AI for Risk Adjustment at RISE National Along with Announces Partnership with Holon Solutions

Retrieved on: 
Thursday, March 14, 2024
ROI, Programmer, Assistant, Partnership, Risk, Patient, Holon, Parikh, Workflow, Neuro-symbolic AI, Heart, API, Health, Medical device

LOUISVILLE, Ky., March 14, 2024 /PRNewswire/ -- In an era when healthcare technology is advancing at an unprecedented pace, RAAPID is at the forefront of applying novel Neuro-Symbolic AI, revolutionizing risk adjustment coding accuracy for payers and providers. With the introduction of its AI technology, RAAPID is setting new standards reducing historical coding variation, and appropriately surfacing and suppressing suspected care gaps in both retrospective and prospective purpose-built risk adjustment solutions. This cutting-edge technology, expert in converting unstructured to structured data while converging the already structured, is clinically trained to navigate the complex landscape of clinical data while adding reasoning to ensure that RAAPID's solutions are advanced, intuitive, and extraordinary in its efficacy.

Key Points: 
  • LOUISVILLE, Ky., March 14, 2024 /PRNewswire/ -- In an era when healthcare technology is advancing at an unprecedented pace, RAAPID is at the forefront of applying novel Neuro-Symbolic AI, revolutionizing risk adjustment coding accuracy for payers and providers.
  • With the introduction of its AI technology, RAAPID is setting new standards reducing historical coding variation, and appropriately surfacing and suppressing suspected care gaps in both retrospective and prospective purpose-built risk adjustment solutions.
  • Its Neuro-Symbolic AI is a testament to the company's commitment to leveraging technology as an AI Assistant for Coders and providers to improve accuracy and impact healthcare outcomes.
  • Chetan Parikh, CEO of RAAPID, expresses immense excitement about the partnership with Holon Solutions.

Liquidia Corporation Files Response to United Therapeutics Lawsuit and Files Counterclaims

Retrieved on: 
Monday, January 8, 2024
Locator, Drug, Federal, UTHR, United Therapeutics, PAH, Hostile witness, PACER, Parikh, Patent, NDA, Therapy, Pharmacology, Shirin David, IPR, Publication, Patient, Journal, Treprostinil, PTAB, Pulmonary hypertension, District court, Exercise, Pharmaceutical industry

11,826,327 (the ‘327 patent) in association with Liquidia’s New Drug Application (NDA) for YUTREPIA™ (treprostinil) inhalation powder.

Key Points: 
  • 11,826,327 (the ‘327 patent) in association with Liquidia’s New Drug Application (NDA) for YUTREPIA™ (treprostinil) inhalation powder.
  • Simultaneously, Liquidia filed counterclaims against UTHR seeking a declaration that all asserted claims of the ‘327 patent are not infringed, are invalid and are unenforceable.
  • Furthermore, the counterclaims summarize certain publications, references and information that UTHR failed to submit to the United States Patent and Trademark Office (USPTO) during the prosecution of the ‘327 patent.
  • Liquidia has also asserted that these same references and information, as set forth in the counterclaims, also render the claims of the ‘327 patent invalid.

AirHop Announces Organizational Changes to Support Global Growth

Retrieved on: 
Tuesday, December 19, 2023
Data Management, Apps, Applications, Technology, Mobile, Wireless, Software, 5G, Artificial Intelligence, IBM, Executive, SMO, Parikh, Deutsche Telekom, Automation, POC, RIC, AirHop Communications, SON, HPE, RAN, Research report, VMware, Radio access network

AirHop Communications , the leading provider of Open RAN (Radio Access Network) Automation and Optimization software for 4G and 5G networks, has announced key organizational changes to support its continued growth objectives.

Key Points: 
  • AirHop Communications , the leading provider of Open RAN (Radio Access Network) Automation and Optimization software for 4G and 5G networks, has announced key organizational changes to support its continued growth objectives.
  • Anand Parikh has been appointed as the new Chief Executive Officer (CEO) of AirHop, effective immediately.
  • These changes will facilitate AirHop’s increasing commercial deployments and revenue growth in 2024 and beyond.
  • Anand, formerly VP of Strategic Partnerships at AirHop, is an entrepreneurial leader with over 35 years of success in high-tech companies.

Nkarta Receives FDA Clearance of IND Application for NKX019 in Lupus Nephritis

Retrieved on: 
Tuesday, October 17, 2023
Investment, Food, Lupus nephritis, Division, Death, Cytarabine, NKG2D, Risk, Rituximab, IND, Safety, University, AML, Conference call, AID, Brattleboro Retreat, Autoimmune disease, Dialysis, FDA, B-cell lymphoma, Workforce, Department of Medicine – University of Pamplona, Lupus, ET, CAR, Immune system, Patient, End organ damage, Rheumatic Disease Clinics of North America, LN, Kidney disease, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, SAN, MRD, NK, University of Massachusetts Chan Medical School, Parikh, Conference, Investigational New Drug, SLE, NHL, Pharmaceutical industry, Vaccine, Cryptocurrency, Nursing, LD, Rheumatology, Medicine

(1)

Key Points: 
  • (1)
    The multi-center, open label, dose escalation clinical trial will assess the safety and clinical activity of NKX019 in patients with refractory LN.
  • “The clearance of Nkarta’s IND for NKX019 in lupus nephritis is an important achievement for Nkarta, and we feel NK cell therapy is ideally suited for the treatment of autoimmune disease,” said Paul J. Hastings, President and CEO of Nkarta.
  • Nkarta announced today the opening of a new cohort in its Phase 1 study of NKX019 in r/r NHL.
  • Nkarta management will discuss its program in autoimmune disease and other corporate updates on Tuesday, October 17, at 8:00 a.m.

FinanceHQ Launches Out of Stealth Mode to Help Match Individuals with Financial Advisors, Names Alex Choi CEO

Retrieved on: 
Tuesday, October 17, 2023
Fintech, Asset Management, Professional Services, Finance, Apple, ABN AMRO, Morgan Stanley, Strategy, RIA, ABN, Adviser, Silicon Valley Bank, Bank of America, Education, Head, Betterment, Bank, Merrill (company), Parikh, Cryptocurrency, Financial adviser, Expedia, Issues in retirement security

FinanceHQ , a platform that connects individuals with trusted financial advisors and resources, has launched out of stealth mode and named Alex Choi as CEO.

Key Points: 
  • FinanceHQ , a platform that connects individuals with trusted financial advisors and resources, has launched out of stealth mode and named Alex Choi as CEO.
  • FinanceHQ was founded to help individuals plan a better financial future.
  • “Financial advisors provide critical guidance to help navigate life's financial milestones.
  • After a rigorous vetting process, FinanceHQ onboards qualified financial advisors and matches them with individuals seeking advice.

myBenefits.ai Welcomes Edward Marx and Paolo Zambito to the Advisory Team

Retrieved on: 
Monday, September 25, 2023
Health Technology, Health Insurance, Data Management, Insurance, Other Health, Technology, Human Resources, Surgery, Practice Management, Professional Services, General Health, Hospitals, Artificial Intelligence, Software, Health, Communication, Independent Payment Advisory Board, Patient education, IDP, New York City Department of Health and Mental Hygiene, Advisory board, Internally displaced person, Stanford University Medical Center, Hospital, Patent, Patient, EHR, Colorectal cancer, CIO, SDK, Pharmaceutical industry, Nursing, Health insurance, Cleveland Clinic, Parikh

myBenefits.ai, an AI-powered platform for personalized post-discharge instructions, streamlined communication, and convenient healthcare support, announced today that Edward Marx, former CIO of Cleveland Clinic, NYC Health, and Paolo Zambito, President of the North Shore Market, have joined the Advisory Board.

Key Points: 
  • myBenefits.ai, an AI-powered platform for personalized post-discharge instructions, streamlined communication, and convenient healthcare support, announced today that Edward Marx, former CIO of Cleveland Clinic, NYC Health, and Paolo Zambito, President of the North Shore Market, have joined the Advisory Board.
  • Edward Marx says, “As a long-time healthcare CIO and author of multiple best-selling books on digital transformation, it became clear that myBenefits.ai filled a major gap in care.
  • To further reinforce the vision for myBenefits.ai, Parikh welcomes industry leaders Edward Marx and Paolo Zambito to the Advisory Board.
  • For more information about DischargePlus and how it could benefit your hospital or healthcare facility, please contact Customer Relations at [email protected] .

Interos Bolsters Executive Ranks with Addition of Industry-Shaping Leaders Across Supply Chain, Product, and Cyber

Retrieved on: 
Monday, July 17, 2023
NIST, Fintech, Private sector, Software as a service, Computer security, SOCOM 4 U.S. Navy SEALs, Commission, Parikh, Risk management, ML, CISA, Strategic planning, Central Waqf Council, Fortune 500, Adeel, Initial public offering, CFO, Growth, Cybersecurity and Infrastructure Security Agency, AI, Product Development Technologies, Commission on Enhancing National Cybersecurity, VC, NIST Cybersecurity Framework, Management, Adviser

ARLINGTON, Va., July 17, 2023 /PRNewswire/ -- Interos, creator of the world's leading AI-powered supply chain resilience platform, today appointed three visionary industry leaders to its senior executive and advisory board leadership teams. The appointments of Kiersten E. Todt (Board of Advisors), Adeel Najmi (Chief Product and Technology Officer) and Jason Parikh (Chief Financial Officer) further accelerate momentum at one of Inc. magazine's Fastest Growing companies in the U.S.

Key Points: 
  • The appointments of deeply knowledgable technology practitioners and thought leaders underscore Interos' mission to fortify fragile global supply chains by delivering end-to-end Resilience By Design TM solutions and dual use technology.
  • Its industry-first platform maps and monitors sub-tier supply chain relationships at scale to pre-empt or minimize systemic risk and stop disruption.
  • Interos Board of Advisors Chair David Warrick cited the new leaders' proven experience addressing critical risk management and resilience challenges.
  • "All three leaders bring a track record of success in tackling complex and challenging global opportunities, and importing external perspectives," he said.

Trellix Appoints Ash Parikh to Chief Marketing Officer

Retrieved on: 
Monday, April 10, 2023
Data Management, Security, Technology, Mobile, Wireless, Software, Networks, Internet, Data management, Software as a service, XDR, Marketing, Parikh, CMO, Informatica, Digital technology, Extended detection and response, Yellowbrick Data, Sales, Trellix

Trellix , the cybersecurity company delivering the future of Extended Detection and Response (XDR), today announced the addition of Ash Parikh to the role of Chief Marketing Officer (CMO).

Key Points: 
  • Trellix , the cybersecurity company delivering the future of Extended Detection and Response (XDR), today announced the addition of Ash Parikh to the role of Chief Marketing Officer (CMO).
  • “Trellix’s XDR platform is helping our customers bolster their cybersecurity programs,” said Bryan Palma, Chief Executive Officer at Trellix.
  • Trellix’s XDR leadership is the perfect opportunity given the ever-increasing threat landscape, and I’m ready to jump right in with my experience in data and cybersecurity,” said Ash Parikh, Chief Marketing Officer at Trellix.
  • “I look forward to telling the Trellix story and advancing the company alongside a world-class global marketing team.”

Patrick Ta Beauty Accelerates Growth with Former Estee Lauder Companies Executive As New CEO

Retrieved on: 
Monday, March 13, 2023
Woman, CFO, Kohl's, CFOS, Love, Beauty, Parikh, Kohl, L'Oréal, Cult Beauty, Growth, EMV, Sephora, Villatoro, Cosmetics, Management

Patrick Ta Beauty brings next-generation artistry together with an exquisite, luxe brand experience, truly unmatched in the industry," said Villatoro.

Key Points: 
  • Patrick Ta Beauty brings next-generation artistry together with an exquisite, luxe brand experience, truly unmatched in the industry," said Villatoro.
  • When asked about the future of Patrick Ta Beauty, Villatoro added, "Patrick Ta Beauty is a brand that is poised for growth.
  • In 2019, renowned makeup artist Patrick Ta worked with product specialist Rima Minasyan and seasoned entrepreneur Avo Minasyan to bring Patrick Ta Beauty to life.
  • Patrick Ta Beauty is currently sold on PatrickTa.com, and retails exclusively on Sephora North America and Canada, Sephora at Kohl's, Cult Beauty and Flannels Beauty.

Former Senior L'Oreal Exec Joins Patrick Ta Beauty

Retrieved on: 
Wednesday, November 30, 2022
Growth, Multimedia, Jared, CFO, Skin, Kohl's, Parikh, Sephora, Kohl, CFOS, L'Oréal, Signet Jewelers, Cosmetics, Jewellery

In 2019, renowned makeup artist Patrick Ta, established product specialist Rima Minasyan, and seasoned entrepreneur Avo Minasyan, brought to life Patrick Ta Beauty.

Key Points: 
  • In 2019, renowned makeup artist Patrick Ta, established product specialist Rima Minasyan, and seasoned entrepreneur Avo Minasyan, brought to life Patrick Ta Beauty.
  • Parikh brings 20+ years of consumer goods finance and operations experience and over a decade in the beauty industry to this exciting time at Patrick Ta Beauty.
  • Avo added "I'm excited to be partnering with Paul to help bring the operations of Patrick Ta Beauty to the next level."
  • Patrick Ta Beauty is currently sold at Sephora North America and Sephora at Kohl's and has a strong consumer base on Patrickta.com in the US.